<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">169</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJMPS.2021.111201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Niosomes as Modern Drug Carrier Systems: Concepts and Advancements&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ghode</surname><given-names>Prashant D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ghode</surname><given-names>Shweta P.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>15</day><month>12</month><year>2021</year></pub-date><volume>2)</volume><issue/><fpage>1</fpage><lpage>8</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Drug delivery systems are formulations that convey medicine to the target site of action inside the body. A good carrier protects the medicine from being broken down or removed quickly, resulting in higher drug concentration in the target tissues. Because of their biodegradability, biocompatibility, and non-immunogenic character, niosomes, which are formed by the self-association of non-ionic surfactants and cholesterol in an aqueous phase, are prospective drug carriers. In recent years, several study articles have been published in scientific publications describing the capacity of niosomes to function as a carrier for the delivery of different types of drugs. The present study examines niosomal drug delivery systems__ampersandsignrsquo; manufacturing processes, characterization methodologies, and latest research, as well as offering up-to-date information on novel niosomal drug delivery applications.&#13;
</p></abstract><kwd-group><kwd>Niosomes</kwd><kwd> Vesicular drug delivery system</kwd><kwd> Components</kwd><kwd> Applications</kwd><kwd> Characterizations</kwd><kwd> Preparation methods</kwd></kwd-group></article-meta></front></article>
